Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
171
¥ millions (year-on-year change in operating income)Wording
Definitive
How definitive the wording is.Contents of this document
Presentation materials for financial resultsFirst quarter of the fiscal year ending March 202710 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥3,287 million+27.1%
Operating profit¥277 million+160.0%
Ordinary income¥263 million+170.0%
Net income¥176 million+179.4%
Gross Profit Margin18.8%
Operating profit margin8.4%
Results for the three months of the current quarter
Net Sales
¥3,287 million
Operating profit
¥277 million
Ordinary income
¥263 million
Net income
¥176 million
Full-year earnings forecast
Net Sales
¥13,102 million
Operating profit
¥904 million
Ordinary income
¥843 million
Net income
¥631 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。not disclosed (progress against the first-half plan was stated as 52.2% for revenue, 83.3% for operating profit, 86.8% for ordinary profit, and 61.8% for net income, among other figures)
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressing smoothly against the planBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
not disclosed (the materials include written explanations of the factors and comparisons of segment profits, but no breakdown of amounts by factor)
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
- Number of home-visit pharmacies5 planned store openings
- Number of home-visit patientsMore than 14,000
- Number of Kirari Prime member stores at fiscal year-endMore than 3,000
- Kirari Prime ARPU¥40.6 10,000/year
New initiatives
- Introduction of a system to semi-automate the administrative work involved in collecting patient co-payments
- Addressing the uneven distribution of pharmacists by using online medication guidance
- Increasing the number of pharmacist consultants and dispatching pharmacists
- Opening the 5th facility in Minami Ward, Fukuoka, in February 2027
- Opening stores in the Tokyo area and northern Chiba area
Key KPIsA metric the company considers important as a management benchmark.
- Number of home-visit pharmacies65 Location
- Number of home-visit patients13,282 People
- Number of Kirari Prime member stores3,023 Location
- Kirari Prime ARPU¥13.1 10,000s/quarter
- Occupancy rate at existing Primary Care Home facilities88 %
- Percentage of patients with severe illnesses15.6 %
Unit price and quantity metricsThese figures show sales broken down by price and volume.
- Number of home-visit patients13,282 People
- Patients per store208 People
- Kirari Prime ARPU¥13.1 10,000s/quarter
- Average monthly charge per Primary Care Home resident¥41 10,000/monthYear on year against the same period last yearFlat
Segment results
- Home-visit pharmacy businessNet Sales2,298Revenue unit¥ millionYear-on-year change in revenue24.5Operating profit179Operating profit unit¥ millionYear-on-year operating profit growth13.7
- Kirari Prime BusinessNet Sales310Revenue unit¥ millionYear-on-year change in revenue19.6Operating profit182Operating profit unit¥ millionYear-on-year operating profit growth37.8
- Primary Care Home businessNet Sales678Revenue unit¥ millionYear-on-year change in revenue41.2Operating profit69Operating profit unit¥ millionYear-on-year operating profit growthReturn to profitability
- Other BusinessesNet Sales0Revenue unit¥ millionOperating profit-7Operating profit unit¥ million
Financial targets
not disclosed (actual figures, including the equity ratio, were provided)Number of stores and locations
Number at period-end65 home-visit pharmacies and 3,023 Kirari Prime member stores
Number of store openings and closures during the periodOpened 3 home-visit pharmacies and transferred 1 store to another business, for a net increase of 2 stores
Number of employees
Number of Employees882 People
Record date31 March 2026
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥3,287 million (YoY +27.1%) |
| Operating profit | ¥277 million (YoY +160.0%) |
| Ordinary income | ¥263 million (YoY +170.0%) |
| Net income | ¥176 million (YoY +179.4%) |
| Gross Profit Margin | 18.8% |
| Operating profit margin | 8.4% |
| Results for the three months of the current quarter | Net Sales ¥3,287 million / Operating profit ¥277 million / Ordinary income ¥263 million / Net income ¥176 million |
| Full-year earnings forecast | Net Sales ¥13,102 million / Operating profit ¥904 million / Ordinary income ¥843 million / Net income ¥631 million |
| Progress against full-year forecast | not disclosed (progress against the first-half plan was stated as 52.2% for revenue, 83.3% for operating profit, 86.8% for ordinary profit, and 61.8% for net income, among other figures) |
| Self-assessment against the plan | Progressing smoothly against the plan |
| Segment results | Segment Home-visit pharmacy business / Net Sales 2,298 / Revenue unit ¥ million / Year-on-year change in revenue 24.5 / Operating profit 179 / Operating profit unit ¥ million / Year-on-year operating profit growth 13.7, Segment Kirari Prime Business / Net Sales 310 / Revenue unit ¥ million / Year-on-year change in revenue 19.6 / Operating profit 182 / Operating profit unit ¥ million / Year-on-year operating profit growth 37.8, Segment Primary Care Home business / Net Sales 678 / Revenue unit ¥ million / Year-on-year change in revenue 41.2 / Operating profit 69 / Operating profit unit ¥ million / Year-on-year operating profit growth Return to profitability, Segment Other Businesses / Net Sales 0 / Revenue unit ¥ million / Year-on-year change in revenue Not disclosed / Operating profit -7 / Operating profit unit ¥ million / Year-on-year operating profit growth Not disclosed |
| Breakdown of Factors Affecting the Change | not disclosed (the materials include written explanations of the factors and comparisons of segment profits, but no breakdown of amounts by factor) |
| Key KPIs | Indicator name Number of home-visit pharmacies / Value 65 Location / Year on year against the same period last year Not disclosed, Indicator name Number of home-visit patients / Value 13,282 People / Year on year against the same period last year Not disclosed, Indicator name Number of Kirari Prime member stores / Value 3,023 Location / Year on year against the same period last year Not disclosed, Indicator name Kirari Prime ARPU / Value ¥13.1 10,000s/quarter / Year on year against the same period last year Not disclosed, Indicator name Occupancy rate at existing Primary Care Home facilities / Value 88 % / Year on year against the same period last year Not disclosed, Indicator name Percentage of patients with severe illnesses / Value 15.6 % / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Indicator name Number of home-visit patients / Value 13,282 People / Year on year against the same period last year Not disclosed, Indicator name Patients per store / Value 208 People / Year on year against the same period last year Not disclosed, Indicator name Kirari Prime ARPU / Value ¥13.1 10,000s/quarter / Year on year against the same period last year Not disclosed, Indicator name Average monthly charge per Primary Care Home resident / Value ¥41 10,000/month / Year on year against the same period last year Flat |
| Number of stores and locations | Number at period-end 65 home-visit pharmacies and 3,023 Kirari Prime member stores / Number of store openings and closures during the period Opened 3 home-visit pharmacies and transferred 1 store to another business, for a net increase of 2 stores |
| Number of employees | Number of Employees 882 People / Record date 31 March 2026 / Changes during the period and hiring plan Not disclosed |
| Assumptions Underlying the Business Outlook | Item Number of home-visit pharmacies / Value 5 planned store openings, Item Number of home-visit patients / Value More than 14,000, Item Number of Kirari Prime member stores at fiscal year-end / Value More than 3,000, Item Kirari Prime ARPU / Value ¥40.6 10,000/year |
| Financial targets | not disclosed (actual figures, including the equity ratio, were provided) |
| New initiatives | Introduction of a system to semi-automate the administrative work involved in collecting patient co-payments, Addressing the uneven distribution of pharmacists by using online medication guidance, Increasing the number of pharmacist consultants and dispatching pharmacists, Opening the 5th facility in Minami Ward, Fukuoka, in February 2027, Opening stores in the Tokyo area and northern Chiba area |
Items this document does not state (10)
Selling, general and administrative expensesRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The benefits of upfront investments, including new store openings, made in the previous fiscal year began to emerge, reducing the cost burden while enabling the company to realize returns from those investments. In the home-visit pharmacy business, stores opened in the previous fiscal year contributed to performance, while in the Primary Care Home business, the 3rd and 4th facilities made full contributions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.